SEC Form 4 · accession 0001127602-16-069427
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Giltner
Director
Period of report
Dec 6, 2016
Accepted (ET)
Dec 7, 2016 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 6, 2016 | M | 5,000 | $41.14 | A | 5,000 | D | |
| Common StockF2 | Dec 6, 2016 | S | 5,000 | $133.3689 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $41.14 | Dec 6, 2016 | M | 5,000 | D | Jun 26, 2010 | Jun 26, 2019 | Common Stock | 5,000 | 25,000 | D |
Explanation of responses
- F1Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F2This transaction was executed in multiple trades at prices ranging from $133.00 to $133.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.